| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G-protein activated inward rectifier potassium channel activity | 3.11e-06 | 4 | 185 | 3 | GO:0015467 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1D GLRA3 SLC24A3 GRIA2 PKD1L2 RYR3 SLC9C1 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A SLC26A6 TMEM63A | 6.17e-06 | 459 | 185 | 16 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | CACNA1D GLRA3 SLC24A3 GRIA2 BCL2 PKD1L2 RYR3 SLC9C1 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A SLC26A6 TMEM63A | 8.28e-06 | 525 | 185 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1D GLRA3 SLC24A3 GRIA2 BCL2 PKD1L2 RYR3 SLC9C1 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A SLC26A6 TMEM63A | 8.49e-06 | 526 | 185 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.54e-05 | 17 | 185 | 4 | GO:0099508 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.97e-05 | 18 | 185 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1D SLC24A3 GRIA2 PKD1L2 RYR3 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A TMEM63A | 1.98e-05 | 343 | 185 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.22e-05 | 37 | 185 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1D GLRA3 GRIA2 RYR3 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A TMEM63A | 6.93e-05 | 334 | 185 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | cholesterol dehydrogenase activity | 8.54e-05 | 2 | 185 | 2 | GO:0102294 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.23e-04 | 28 | 185 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | protein kinase binding | TRIM49 SRC TRIM49C GRIA2 CNKSR2 ARHGEF16 ADCY6 IFNAR2 CRY2 MAPK14 KIDINS220 FAM83F SKAP1 ELP2 LRRC7 FGR CCDC102B IKBKB TRIM49B TRIM48 | 1.80e-04 | 873 | 185 | 20 | GO:0019901 |
| GeneOntologyMolecularFunction | BMP receptor binding | 2.09e-04 | 13 | 185 | 3 | GO:0070700 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.28e-04 | 93 | 185 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | kinase binding | TRIM49 SRC TRIM49C GRIA2 DGKH CNKSR2 ARHGEF16 ADCY6 IFNAR2 CRY2 MAPK14 KIDINS220 FAM83F SKAP1 ELP2 LRRC7 FGR CCDC102B IKBKB TRIM49B TRIM48 | 2.63e-04 | 969 | 185 | 21 | GO:0019900 |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 5.76e-04 | 18 | 185 | 3 | GO:0008381 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1D ATP6V1B1 GLRA3 SLC24A3 GRIA2 ATP10B ATP9B BCL2 PKD1L2 SVOPL RYR3 MFSD14A SLC9C1 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A SLC35F6 ABCB11 SLC26A6 TMEM63A | 8.57e-04 | 1289 | 185 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.01e-03 | 123 | 185 | 6 | GO:0030165 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1D ATP6V1B1 GLRA3 SLC24A3 GRIA2 PKD1L2 RYR3 SLC9C1 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A SLC26A6 TMEM63A | 1.16e-03 | 793 | 185 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | 3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity | 1.25e-03 | 6 | 185 | 2 | GO:0003854 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.28e-03 | 339 | 185 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1D ATP6V1B1 SLC24A3 GRIA2 PKD1L2 RYR3 SLC9C1 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A TMEM63A | 1.36e-03 | 664 | 185 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1D SLC24A3 GRIA2 PKD1L2 RYR3 SLC9C1 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A | 1.37e-03 | 465 | 185 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1D ATP6V1B1 GLRA3 SLC24A3 GRIA2 BCL2 PKD1L2 SVOPL RYR3 MFSD14A SLC9C1 PIEZO2 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A SLC35F6 ABCB11 SLC26A6 TMEM63A | 1.40e-03 | 1180 | 185 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 1.74e-03 | 7 | 185 | 2 | GO:0004769 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1B1 EP400 RNF213 ATP10B ATP9B DNAH14 DDX3X MSH6 DNAH17 ENTPD2 ABCB11 MACF1 DNAH6 DNAH8 | 1.80e-03 | 614 | 185 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1D ATP6V1B1 GLRA3 SLC24A3 GRIA2 PKD1L2 RYR3 SLC9C1 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A SLC26A6 TMEM63A | 1.89e-03 | 758 | 185 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase binding | 1.94e-03 | 27 | 185 | 3 | GO:0070696 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.96e-03 | 140 | 185 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 2.16e-03 | 28 | 185 | 3 | GO:0005242 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1D ATP6V1B1 SLC24A3 GRIA2 PKD1L2 RYR3 SLC9C1 NALF1 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A TMEM63A | 2.18e-03 | 627 | 185 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.19e-03 | 193 | 185 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 2.19e-03 | 98 | 185 | 5 | GO:0048306 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.30e-03 | 8 | 185 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 2.30e-03 | 8 | 185 | 2 | GO:0000253 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.45e-03 | 197 | 185 | 7 | GO:0022834 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1D NLGN4Y SYNE1 SRC SYT6 GLRA3 GRIA2 CNKSR2 LRP8 NEO1 NLGN4X KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A LRRC7 UNC13A | 4.94e-06 | 583 | 186 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | excitatory synapse | 5.20e-06 | 107 | 186 | 8 | GO:0060076 | |
| GeneOntologyCellularComponent | dynein complex | 1.17e-04 | 54 | 186 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | glutamatergic synapse | NLGN4Y DISC1 SRC SYT6 ADGRB2 GRIA2 CNKSR2 LRP8 USP8 NEO1 MAPK14 NLGN4X PLXNC1 SCN2A SNX27 LRRC7 CDH6 UNC13A | 3.79e-04 | 817 | 186 | 18 | GO:0098978 |
| GeneOntologyCellularComponent | mitochondrial crista | 4.30e-04 | 17 | 186 | 3 | GO:0030061 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 4.51e-04 | 201 | 186 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 4.67e-04 | 4 | 186 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 5.23e-04 | 157 | 186 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | microtubule associated complex | 6.08e-04 | 161 | 186 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | glycinergic synapse | 7.07e-04 | 20 | 186 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | presynaptic membrane | 8.69e-04 | 277 | 186 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | host intracellular region | 1.15e-03 | 6 | 186 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 1.15e-03 | 6 | 186 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 1.15e-03 | 6 | 186 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 1.15e-03 | 6 | 186 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 1.15e-03 | 6 | 186 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 1.15e-03 | 6 | 186 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 1.15e-03 | 6 | 186 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.22e-03 | 24 | 186 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.35e-03 | 238 | 186 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.38e-03 | 25 | 186 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | sarcolemma | 1.60e-03 | 190 | 186 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | postsynaptic specialization | NLGN4Y DISC1 SRC GLRA3 GRIA2 CNKSR2 LRP8 USP8 NEO1 NLGN4X MACF1 LRRC7 | 1.89e-03 | 503 | 186 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1D GLRA3 GRIA2 RYR3 KCNJ3 KCNJ6 SCN1A KCNJ9 SCN2A SLC26A6 | 2.13e-03 | 378 | 186 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | axon initial segment | 2.14e-03 | 29 | 186 | 3 | GO:0043194 | |
| Domain | Spectrin_repeat | 8.39e-06 | 29 | 183 | 5 | IPR002017 | |
| Domain | SPRY | 3.86e-05 | 94 | 183 | 7 | PF00622 | |
| Domain | SPRY_dom | 3.86e-05 | 94 | 183 | 7 | IPR003877 | |
| Domain | B30.2/SPRY | 4.13e-05 | 95 | 183 | 7 | IPR001870 | |
| Domain | B302_SPRY | 4.13e-05 | 95 | 183 | 7 | PS50188 | |
| Domain | Spectrin | 6.83e-05 | 23 | 183 | 4 | PF00435 | |
| Domain | ACTININ_2 | 6.83e-05 | 23 | 183 | 4 | PS00020 | |
| Domain | ACTININ_1 | 6.83e-05 | 23 | 183 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 6.83e-05 | 23 | 183 | 4 | IPR001589 | |
| Domain | NLGN4 | 9.55e-05 | 2 | 183 | 2 | IPR030025 | |
| Domain | SPRY | 2.13e-04 | 87 | 183 | 6 | SM00449 | |
| Domain | SPEC | 2.59e-04 | 32 | 183 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.59e-04 | 32 | 183 | 4 | IPR018159 | |
| Domain | Rubis-subs-bind | 2.85e-04 | 3 | 183 | 2 | PF09273 | |
| Domain | Rubisco_LSMT_subst-bd | 2.85e-04 | 3 | 183 | 2 | IPR015353 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.11e-04 | 14 | 183 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.11e-04 | 14 | 183 | 3 | IPR024743 | |
| Domain | MT | 3.11e-04 | 14 | 183 | 3 | PF12777 | |
| Domain | AAA_8 | 3.11e-04 | 14 | 183 | 3 | PF12780 | |
| Domain | DH_1 | 3.79e-04 | 63 | 183 | 5 | PS00741 | |
| Domain | DHC_fam | 3.86e-04 | 15 | 183 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 3.86e-04 | 15 | 183 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.86e-04 | 15 | 183 | 3 | IPR004273 | |
| Domain | PH | NET1 ARHGEF5 DGKH CNKSR2 ARHGEF16 SPTBN5 CMIP SKAP1 PLCL2 AKAP13 | 4.29e-04 | 278 | 183 | 10 | SM00233 |
| Domain | CH | 4.39e-04 | 65 | 183 | 5 | SM00033 | |
| Domain | PH_DOMAIN | NET1 ARHGEF5 DGKH CNKSR2 ARHGEF16 SPTBN5 CMIP SKAP1 PLCL2 AKAP13 | 4.42e-04 | 279 | 183 | 10 | PS50003 |
| Domain | PH_domain | NET1 ARHGEF5 DGKH CNKSR2 ARHGEF16 SPTBN5 CMIP SKAP1 PLCL2 AKAP13 | 4.54e-04 | 280 | 183 | 10 | IPR001849 |
| Domain | - | WSB1 WDR5B BIRC6 TBL3 ERCC8 NBAS GTF3C2 WDR97 PLXNC1 ELP2 WDR72 | 4.59e-04 | 333 | 183 | 11 | 2.130.10.10 |
| Domain | IRK | 4.72e-04 | 16 | 183 | 3 | PF01007 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 4.72e-04 | 16 | 183 | 3 | IPR013518 | |
| Domain | - | 4.72e-04 | 16 | 183 | 3 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 4.72e-04 | 16 | 183 | 3 | IPR016449 | |
| Domain | WD40/YVTN_repeat-like_dom | WSB1 WDR5B BIRC6 TBL3 ERCC8 NBAS GTF3C2 WDR97 PLXNC1 ELP2 WDR72 | 4.82e-04 | 335 | 183 | 11 | IPR015943 |
| Domain | RhoGEF | 5.41e-04 | 68 | 183 | 5 | SM00325 | |
| Domain | BBOX | 5.79e-04 | 69 | 183 | 5 | SM00336 | |
| Domain | Butyrophylin | 6.18e-04 | 70 | 183 | 5 | IPR003879 | |
| Domain | RhoGEF | 6.18e-04 | 70 | 183 | 5 | PF00621 | |
| Domain | CH | 6.18e-04 | 70 | 183 | 5 | PF00307 | |
| Domain | DH_2 | 6.18e-04 | 70 | 183 | 5 | PS50010 | |
| Domain | - | 6.60e-04 | 71 | 183 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 6.60e-04 | 71 | 183 | 5 | IPR000219 | |
| Domain | - | 6.60e-04 | 71 | 183 | 5 | 1.10.418.10 | |
| Domain | - | 6.60e-04 | 71 | 183 | 5 | 4.10.45.10 | |
| Domain | zf-B_box | 7.04e-04 | 72 | 183 | 5 | PF00643 | |
| Domain | CH | 7.49e-04 | 73 | 183 | 5 | PS50021 | |
| Domain | CH-domain | 8.48e-04 | 75 | 183 | 5 | IPR001715 | |
| Domain | Nlgn | 9.36e-04 | 5 | 183 | 2 | IPR000460 | |
| Domain | - | ATP6V1B1 EP400 GBP7 MFHAS1 IFI44 RNF213 DNAH14 DDX3X MSH6 GBP4 HNRNPUL2 N4BP2 ABCB11 RAB32 DNAH6 DNAH8 NLRP13 | 1.09e-03 | 746 | 183 | 17 | 3.40.50.300 |
| Domain | ZF_BBOX | 1.14e-03 | 80 | 183 | 5 | PS50119 | |
| Domain | WD40_repeat_CS | 1.18e-03 | 164 | 183 | 7 | IPR019775 | |
| Domain | Znf_B-box | 1.20e-03 | 81 | 183 | 5 | IPR000315 | |
| Domain | - | 1.40e-03 | 6 | 183 | 2 | 3.90.1290.10 | |
| Domain | Na_trans_cytopl | 1.40e-03 | 6 | 183 | 2 | PF11933 | |
| Domain | PQQ_repeat | 1.40e-03 | 6 | 183 | 2 | IPR002372 | |
| Domain | Na_trans_cytopl | 1.40e-03 | 6 | 183 | 2 | IPR024583 | |
| Domain | 3Beta_HSD | 1.40e-03 | 6 | 183 | 2 | PF01073 | |
| Domain | - | 1.40e-03 | 6 | 183 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 1.40e-03 | 6 | 183 | 2 | IPR027295 | |
| Domain | 3Beta_OHSteriod_DH/Estase | 1.40e-03 | 6 | 183 | 2 | IPR002225 | |
| Domain | WD_REPEATS_1 | 1.72e-03 | 278 | 183 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.77e-03 | 279 | 183 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.77e-03 | 279 | 183 | 9 | PS50294 | |
| Domain | PH | 1.93e-03 | 229 | 183 | 8 | PF00169 | |
| Domain | ARM-type_fold | RALGAPA1 ZYG11A USP24 RYR3 FOCAD XPO6 ANKAR ULK4 CFAP69 GCN1 | 1.93e-03 | 339 | 183 | 10 | IPR016024 |
| Domain | Plectin | 1.94e-03 | 7 | 183 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.94e-03 | 7 | 183 | 2 | IPR001101 | |
| Domain | PLEC | 1.94e-03 | 7 | 183 | 2 | SM00250 | |
| Domain | PH_dom-like | NET1 ARHGEF5 ECT2L DGKH CNKSR2 ARHGEF16 SPTBN5 CMIP SKAP1 PLCL2 AKAP13 | 3.27e-03 | 426 | 183 | 11 | IPR011993 |
| Domain | Na_channel_asu | 4.08e-03 | 10 | 183 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 4.08e-03 | 10 | 183 | 2 | IPR010526 | |
| Domain | GBP_C | 4.08e-03 | 10 | 183 | 2 | PF02841 | |
| Domain | Na_trans_assoc | 4.08e-03 | 10 | 183 | 2 | PF06512 | |
| Domain | WD40 | 4.09e-03 | 259 | 183 | 8 | PF00400 | |
| Domain | P-loop_NTPase | ATP6V1B1 EP400 GBP7 MFHAS1 IFI44 RNF213 DNAH14 DDX3X MSH6 GBP4 HNRNPUL2 N4BP2 ABCB11 RAB32 DNAH6 DNAH8 NLRP13 | 4.14e-03 | 848 | 183 | 17 | IPR027417 |
| Domain | GPS | 4.43e-03 | 34 | 183 | 3 | SM00303 | |
| Domain | GPS | 4.81e-03 | 35 | 183 | 3 | PF01825 | |
| Domain | G_GB1_RHD3_dom | 4.95e-03 | 11 | 183 | 2 | IPR030386 | |
| Domain | Guanylate-bd_N | 4.95e-03 | 11 | 183 | 2 | IPR015894 | |
| Domain | Guanylate-bd_C | 4.95e-03 | 11 | 183 | 2 | IPR003191 | |
| Domain | GBP | 4.95e-03 | 11 | 183 | 2 | PF02263 | |
| Domain | G_GB1_RHD3 | 4.95e-03 | 11 | 183 | 2 | PS51715 | |
| Domain | WD40 | 5.02e-03 | 268 | 183 | 8 | SM00320 | |
| Domain | GPS | 5.21e-03 | 36 | 183 | 3 | PS50221 | |
| Domain | - | NET1 ARHGEF5 ECT2L DGKH CNKSR2 ARHGEF16 SPTBN5 SKAP1 PLCL2 AKAP13 | 5.31e-03 | 391 | 183 | 10 | 2.30.29.30 |
| Domain | Ion_trans_dom | 5.31e-03 | 114 | 183 | 5 | IPR005821 | |
| Domain | Ion_trans | 5.31e-03 | 114 | 183 | 5 | PF00520 | |
| Domain | WD40_repeat | 5.47e-03 | 272 | 183 | 8 | IPR001680 | |
| Domain | GPS | 5.63e-03 | 37 | 183 | 3 | IPR000203 | |
| Domain | Peptidase_M28 | 5.91e-03 | 12 | 183 | 2 | PF04389 | |
| Domain | Peptidase_M28 | 5.91e-03 | 12 | 183 | 2 | IPR007484 | |
| Domain | ConA-like_dom | 5.92e-03 | 219 | 183 | 7 | IPR013320 | |
| Domain | GDS_CDC24_CS | 6.53e-03 | 39 | 183 | 3 | IPR001331 | |
| Domain | Carboxylesterase_B_CS | 6.94e-03 | 13 | 183 | 2 | IPR019819 | |
| Domain | UBIQUITIN_CONJUGAT_1 | 7.01e-03 | 40 | 183 | 3 | PS00183 | |
| Domain | UBIQUITIN_CONJUGAT_2 | 7.51e-03 | 41 | 183 | 3 | PS50127 | |
| Domain | UBQ-conjugat_E2 | 7.51e-03 | 41 | 183 | 3 | IPR000608 | |
| Domain | CARBOXYLESTERASE_B_2 | 8.04e-03 | 14 | 183 | 2 | PS00941 | |
| Domain | Dynein_heavy_dom-2 | 8.04e-03 | 14 | 183 | 2 | IPR013602 | |
| Domain | DHC_N2 | 8.04e-03 | 14 | 183 | 2 | PF08393 | |
| Domain | P_typ_ATPase_c | 8.04e-03 | 14 | 183 | 2 | IPR032630 | |
| Pubmed | 1.04e-07 | 9 | 189 | 4 | 12297500 | ||
| Pubmed | 1.58e-07 | 3 | 189 | 3 | 7702616 | ||
| Pubmed | 1.58e-07 | 3 | 189 | 3 | 22098295 | ||
| Pubmed | Behavioral characterization of mice lacking GIRK/Kir3 channel subunits. | 1.58e-07 | 3 | 189 | 3 | 18194467 | |
| Pubmed | 1.58e-07 | 3 | 189 | 3 | 9459542 | ||
| Pubmed | Molecular and cellular diversity of neuronal G-protein-gated potassium channels. | 1.58e-07 | 3 | 189 | 3 | 16339040 | |
| Pubmed | Altered neurotransmission in the mesolimbic reward system of Girk mice. | 1.58e-07 | 3 | 189 | 3 | 20557431 | |
| Pubmed | 1.58e-07 | 3 | 189 | 3 | 15028774 | ||
| Pubmed | 1.58e-07 | 3 | 189 | 3 | 15459198 | ||
| Pubmed | Modulation of steroidogenic enzymes in murine lymphoid organs after immune activation. | 1.58e-07 | 3 | 189 | 3 | 19172483 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CERS2 ATP6V1B1 DSC3 WFS1 TTC27 RNF213 ADCY6 LRP8 FOCAD USP8 HARS2 NEO1 CMIP TMTC4 NR5A2 SLC35F6 SNX27 MACF1 BAMBI RAB32 WDR72 | 3.79e-07 | 1061 | 189 | 21 | 33845483 |
| Pubmed | EP400 SYNE1 CNKSR2 URB2 ADCY6 FOCAD USP8 KIDINS220 PLCL2 OGFOD1 SNX27 MACF1 LRRC7 | 4.12e-07 | 407 | 189 | 13 | 12693553 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | RALGAPA1 IQGAP2 NLGN4Y SYNE1 SRC ADGRB2 GRIA2 CNKSR2 NLGN4X MACF1 LRRC7 | 4.53e-07 | 281 | 189 | 11 | 28706196 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 TPRA1 NLGN4Y ACP3 SRC AFF3 RNF213 ATP9B DGKH ARHGEF16 NAALADL2 DNAH14 LRP8 KIAA1671 CMIP KIDINS220 KCNJ3 ANKAR ZNF589 MACF1 AKAP13 LRRC7 CFAP69 CNOT1 TMEM63A | 5.91e-07 | 1489 | 189 | 25 | 28611215 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RALGAPA1 DSC3 IQGAP2 SRC ARHGEF16 ADCY6 LRP8 NEO1 PIEZO2 KIDINS220 NLGN4X FAM83F PLXNC1 VPS51 SLC26A6 | 5.98e-07 | 569 | 189 | 15 | 30639242 |
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 21286865 | ||
| Pubmed | Molecular properties of neuronal G-protein-activated inwardly rectifying K+ channels. | 6.29e-07 | 4 | 189 | 3 | 7499385 | |
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 20023637 | ||
| Pubmed | Functional analysis of the weaver mutant GIRK2 K+ channel and rescue of weaver granule cells. | 6.29e-07 | 4 | 189 | 3 | 8630252 | |
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 11891065 | ||
| Pubmed | Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. | 6.29e-07 | 4 | 189 | 3 | 16109170 | |
| Pubmed | Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum. | 6.29e-07 | 4 | 189 | 3 | 18088366 | |
| Pubmed | 1.10e-06 | 15 | 189 | 4 | 19703589 | ||
| Pubmed | 1.57e-06 | 5 | 189 | 3 | 33402420 | ||
| Pubmed | 1.57e-06 | 5 | 189 | 3 | 19558451 | ||
| Pubmed | 1.57e-06 | 5 | 189 | 3 | 7926018 | ||
| Pubmed | Palatal adhesion is dependent on Src family kinases and p38MAPK. | 1.57e-06 | 5 | 189 | 3 | 25354453 | |
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 3.07e-06 | 19 | 189 | 4 | 22144910 | |
| Pubmed | BCORL1 USP24 TTC27 C15orf39 BIRC6 KIAA1671 GTF3C2 ANAPC1 N4BP2 PLEC GCN1 CNOT1 | 3.49e-06 | 418 | 189 | 12 | 34709266 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EP400 ARHGEF5 DISC1 CNKSR2 TSG101 CCDC141 KIAA1671 KCNJ3 SCN1A AKAP13 PLEC FHIP1A | 4.65e-06 | 430 | 189 | 12 | 35044719 |
| Pubmed | 5.44e-06 | 7 | 189 | 3 | 23131831 | ||
| Pubmed | 9.12e-06 | 187 | 189 | 8 | 26460568 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 1.25e-05 | 55 | 189 | 5 | 19468303 | |
| Pubmed | 1.33e-05 | 197 | 189 | 8 | 36604605 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DISC1 BCORL1 RNF213 DGKH ZNF226 TEKT5 BIRC6 DNAH14 KIAA1671 FOCAD MSH6 KCNJ9 AKAP13 LRRC7 CNOT1 | 1.35e-05 | 736 | 189 | 15 | 29676528 |
| Pubmed | EMC1 WFS1 USP24 ADGRB2 GRIA2 CNKSR2 TSG101 BIRC6 NEO1 HNRNPUL2 KCNJ3 SCN1A MACF1 LRRC7 PLEC VPS51 GCN1 CNOT1 UNC13A | 1.60e-05 | 1139 | 189 | 19 | 36417873 | |
| Pubmed | CERS2 EMC1 QPCTL EP400 NET1 SYNE1 ECT2L URB2 TEKT5 TBL3 PCF11 KIAA1671 INTS10 MSH6 HARS2 KIDINS220 GTF3C2 ANAPC1 SLC35F6 MACF1 DNAJC1 FHIP1A | 2.36e-05 | 1497 | 189 | 22 | 31527615 | |
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 2.52e-05 | 11 | 189 | 3 | 39256359 | |
| Pubmed | Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol. | 2.94e-05 | 2 | 189 | 2 | 14665668 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 21142871 | ||
| Pubmed | Isolation of duplicated human c-src genes located on chromosomes 1 and 20. | 2.94e-05 | 2 | 189 | 2 | 2581127 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.94e-05 | 2 | 189 | 2 | 10827969 | |
| Pubmed | Chaperones rejuvenate folding and activity of 3-β hydroxysteroid dehydrogenase 2. | 2.94e-05 | 2 | 189 | 2 | 23485106 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 19694741 | ||
| Pubmed | Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor. | 2.94e-05 | 2 | 189 | 2 | 17548836 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 18524572 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 19414525 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.94e-05 | 2 | 189 | 2 | 1317301 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 35314385 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 18778748 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 9029734 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 9029733 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 2243100 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 12205101 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 23183221 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 24075909 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 31439038 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 24855039 | ||
| Pubmed | Hypoxia-induced Bcl-2 expression in endothelial cells via p38 MAPK pathway. | 2.94e-05 | 2 | 189 | 2 | 20307495 | |
| Pubmed | 3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma. | 2.94e-05 | 2 | 189 | 2 | 25458695 | |
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 2.94e-05 | 2 | 189 | 2 | 37001827 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 12050213 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 7608280 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 23090968 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 16538384 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 23219908 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 15814785 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 8929423 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 18622426 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 20660004 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 2.94e-05 | 2 | 189 | 2 | 15249644 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 34550611 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 24126923 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 20805499 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 10956667 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 14764797 | ||
| Pubmed | High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians. | 2.94e-05 | 2 | 189 | 2 | 37274334 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 37621179 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 1924345 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 12040038 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 21300758 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 28487514 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 16478974 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 30693367 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 30851938 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 29649454 | ||
| Pubmed | Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice. | 2.94e-05 | 2 | 189 | 2 | 18400906 | |
| Pubmed | Bcl-2 Phosphorylation by p38 MAPK: identification of target sites and biologic consequences. | 2.94e-05 | 2 | 189 | 2 | 16714293 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 14671206 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 7626443 | ||
| Pubmed | Placental antiangiogenic prolactin fragments are increased in human and rat maternal diabetes. | 2.94e-05 | 2 | 189 | 2 | 24984282 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 18434543 | ||
| Pubmed | Bone secreted factors induce cellular quiescence in prostate cancer cells. | 2.94e-05 | 2 | 189 | 2 | 31819067 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 33096315 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 8145763 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 15292044 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 2.94e-05 | 2 | 189 | 2 | 37080762 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 16846696 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 29106499 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 26311622 | ||
| GeneFamily | Dyneins, axonemal | 4.53e-06 | 17 | 123 | 4 | 536 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.61e-05 | 66 | 123 | 5 | 722 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 1.61e-04 | 16 | 123 | 3 | 276 | |
| GeneFamily | WD repeat domain containing | 4.28e-04 | 262 | 123 | 8 | 362 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.77e-04 | 95 | 123 | 5 | 59 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.25e-03 | 8 | 123 | 2 | 939 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.60e-03 | 9 | 123 | 2 | 1203 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 2.43e-03 | 11 | 123 | 2 | 455 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.87e-03 | 206 | 123 | 6 | 682 | |
| GeneFamily | ATPase phospholipid transporting | 4.55e-03 | 15 | 123 | 2 | 1210 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | RALGAPA1 WSB1 CACNA1D USP24 ATP9B NAALADL2 DNAH14 SCN2A SKAP1 WDR72 | 2.79e-06 | 208 | 188 | 10 | M39233 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1D SYNE1 AFF3 GRIA2 CNKSR2 FOCAD NALF1 KCNJ3 SCN1A SCN2A LRRC7 | 9.39e-10 | 198 | 189 | 11 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1D SYNE1 AFF3 GRIA2 CNKSR2 FOCAD NALF1 KCNJ3 SCN1A SCN2A LRRC7 | 9.39e-10 | 198 | 189 | 11 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | WSB1 MFHAS1 USP24 EYA1 NAALADL2 SVOPL NALF1 SCN2A SKAP1 FHIP1A | 7.99e-09 | 187 | 189 | 10 | f124d2c699b717b7c02a1a70493f515b83dc2f4c |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1D SYNE1 AFF3 GRIA2 CNKSR2 FOCAD NALF1 KCNJ3 SCN2A LRRC7 | 1.25e-08 | 196 | 189 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CACNA1D AFF3 SYT6 SLC24A3 CNKSR2 NAALADL2 NR2F1 PIEZO2 NALF1 MACF1 | 1.31e-08 | 197 | 189 | 10 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CACNA1D AFF3 SYT6 SLC24A3 CNKSR2 NAALADL2 NR2F1 PIEZO2 NALF1 MACF1 | 1.31e-08 | 197 | 189 | 10 | 11a4c417f035e554431a8f03be13b5eefa3530c0 |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | CACNA1D SLC24A3 HPSE2 NAALADL2 NR2F1 DNAH14 NEO1 PIEZO2 MACF1 CCDC102B | 1.31e-08 | 197 | 189 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | SYNE1 AFF3 GRIA2 CNKSR2 FOCAD NALF1 KCNJ3 SCN1A SCN2A UNC13A | 1.38e-08 | 198 | 189 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CACNA1D SYNE1 AFF3 GRIA2 CNKSR2 FOCAD NALF1 KCNJ3 SCN1A SCN2A | 1.38e-08 | 198 | 189 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 187 | 189 | 9 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | CACNA1D MFHAS1 USP24 SLC24A3 NAALADL2 NALF1 SCN2A SKAP1 FHIP1A | 1.17e-07 | 188 | 189 | 9 | df1fd0819d301679f3c9ea404e942e39095912eb |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 189 | 189 | 9 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 189 | 189 | 9 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 189 | 189 | 9 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CACNA1D HPSE2 CNKSR2 NAALADL2 NR2F1 PIEZO2 NALF1 MACF1 CCDC102B | 1.47e-07 | 193 | 189 | 9 | 9f69edc97b868d23998abc98928a2e89a885ef8a |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-07 | 199 | 189 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.99e-07 | 200 | 189 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.53e-07 | 161 | 189 | 8 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 184 | 189 | 8 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.49e-06 | 131 | 189 | 7 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 131 | 189 | 7 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 189 | 189 | 8 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-06 | 189 | 189 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.58e-06 | 190 | 189 | 8 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.71e-06 | 192 | 189 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.85e-06 | 194 | 189 | 8 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 136 | 189 | 7 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.07e-06 | 197 | 189 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.32e-06 | 200 | 189 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 145 | 189 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 4.95e-06 | 157 | 189 | 7 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.60e-06 | 160 | 189 | 7 | 60fa1c717410aad7e8647703cb416cd7617cac29 | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 5.84e-06 | 161 | 189 | 7 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 7.71e-06 | 168 | 189 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.66e-06 | 171 | 189 | 7 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-05 | 175 | 189 | 7 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 178 | 189 | 7 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 179 | 189 | 7 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 180 | 189 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 181 | 189 | 7 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.30e-05 | 182 | 189 | 7 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 182 | 189 | 7 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 184 | 189 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 184 | 189 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 184 | 189 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 185 | 189 | 7 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-05 | 186 | 189 | 7 | 1587667e5084ac43505d027af925ba711e228150 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.49e-05 | 186 | 189 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 187 | 189 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 187 | 189 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 187 | 189 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 125 | 189 | 6 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-05 | 188 | 189 | 7 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.60e-05 | 188 | 189 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.66e-05 | 189 | 189 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 1.71e-05 | 190 | 189 | 7 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 190 | 189 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 191 | 189 | 7 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 191 | 189 | 7 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-05 | 192 | 189 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 193 | 189 | 7 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 193 | 189 | 7 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 194 | 189 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 194 | 189 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-05 | 194 | 189 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 194 | 189 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 194 | 189 | 7 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | (4)_Endothelial_cells-(4)_Lymph_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.96e-05 | 194 | 189 | 7 | 9735b86d3b2480a0b34d8aab8e7bd609d83c2454 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 194 | 189 | 7 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-05 | 195 | 189 | 7 | a2fe352682f548001ca2ee056e7a54af10134453 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 195 | 189 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 195 | 189 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 195 | 189 | 7 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-05 | 196 | 189 | 7 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 196 | 189 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-05 | 196 | 189 | 7 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 196 | 189 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 196 | 189 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-05 | 196 | 189 | 7 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 196 | 189 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.16e-05 | 197 | 189 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 198 | 189 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-05 | 199 | 189 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_Myelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-05 | 199 | 189 | 7 | 2b567b6fd8addf059bbf2b72c55a7647aefdc595 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-05 | 199 | 189 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-05 | 200 | 189 | 7 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-05 | 200 | 189 | 7 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.38e-05 | 200 | 189 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_T_naive|Influenza_Severe / Disease, condition lineage and cell class | 2.38e-05 | 200 | 189 | 7 | 0382f8fc27d18003761725e714beb6b3f3150057 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-05 | 200 | 189 | 7 | 88d713dfc792e7609bf7ecfb28f87cb748088570 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.38e-05 | 200 | 189 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-05 | 200 | 189 | 7 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 135 | 189 | 6 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.45e-05 | 81 | 189 | 5 | 20796e59cdeb398e7772f4356578d74a33405f71 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 144 | 189 | 6 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.40e-05 | 150 | 189 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.56e-05 | 151 | 189 | 6 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-05 | 152 | 189 | 6 | 655d47efe0608d729801f1f01668e84c1bc0675f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-05 | 156 | 189 | 6 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 161 | 189 | 6 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| Drug | bifeprunox | 2.97e-06 | 13 | 187 | 4 | CID000208951 | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | ATP6V1B1 SLC24A3 ATP9B NR2F1 PIGC ZNF589 PLCL2 AKAP13 CPLANE1 TBX6 | 5.86e-06 | 198 | 187 | 10 | 2638_UP |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | DISC1 ACP3 PEX3 SLC24A3 NR2F1 SPTBN5 MAPK14 PLXNC1 PLCL2 NR5A2 | 5.86e-06 | 198 | 187 | 10 | 3324_UP |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; HL60; HT_HG-U133A | RALGAPA1 BMP1 ERCC8 BMP7 KIDINS220 ZNF589 DNAJC1 CDH6 TMEM63A TBX6 | 5.86e-06 | 198 | 187 | 10 | 6137_DN |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A | CACNA1D ATP6V1B1 DISC1 ATP10B CNKSR2 BMP1 MAPK14 NR5A2 FGR CFAP69 | 6.13e-06 | 199 | 187 | 10 | 2309_UP |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | RALGAPA1 QPCTL ATP10B ARHGEF16 DDX3X CRY2 ERCC8 PLXNC1 IKBKB CFAP69 | 6.13e-06 | 199 | 187 | 10 | 6317_UP |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.87e-05 | 190 | 187 | 9 | 6807_DN | |
| Drug | Duloxetine Hydrochloride | 2.96e-05 | 8 | 187 | 3 | ctd:D000068736 | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.00e-05 | 191 | 187 | 9 | 3926_DN | |
| Drug | 0297417-0002B [362658-29-5]; Down 200; 10uM; PC3; HT_HG-U133A | 3.38e-05 | 194 | 187 | 9 | 6895_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.38e-05 | 194 | 187 | 9 | 6958_DN | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 3.38e-05 | 194 | 187 | 9 | 2793_DN | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 3.67e-05 | 196 | 187 | 9 | 5926_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | CACNA1D MFHAS1 SRC SLC24A3 ATP9B ERN2 KIDINS220 AKAP13 IKBKB | 3.67e-05 | 196 | 187 | 9 | 7025_UP |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 3.67e-05 | 196 | 187 | 9 | 3435_UP | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.67e-05 | 196 | 187 | 9 | 2811_DN | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; HL60; HT_HG-U133A | 3.82e-05 | 197 | 187 | 9 | 3064_DN | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 3.82e-05 | 197 | 187 | 9 | 6988_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.82e-05 | 197 | 187 | 9 | 2810_UP | |
| Drug | Ginkgolide A [15291-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 3260_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 3895_DN | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 2170_UP | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; PC3; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 4667_UP | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 4551_DN | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; HL60; HT_HG-U133A | 3.97e-05 | 198 | 187 | 9 | 1838_DN | |
| Drug | 1-chloro-1,2,2-trifluorocyclobutane | 4.12e-05 | 24 | 187 | 4 | CID000079091 | |
| Drug | alpha-estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A | 4.13e-05 | 199 | 187 | 9 | 1210_DN | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A | RALGAPA1 CACNA1D ACP3 PEX3 GLRA3 SLC24A3 PLXNC1 ZNF589 TMEM63A | 4.13e-05 | 199 | 187 | 9 | 5534_UP |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.29e-05 | 200 | 187 | 9 | 7030_UP | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.29e-05 | 200 | 187 | 9 | 4213_DN | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 4.29e-05 | 200 | 187 | 9 | 3328_UP | |
| Drug | Amoxapine | 4.42e-05 | 9 | 187 | 3 | ctd:D000657 | |
| Drug | 3-oxo-delta 5-steroid | 6.71e-05 | 2 | 187 | 2 | CID000439372 | |
| Drug | 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea | 6.71e-05 | 2 | 187 | 2 | DB06882 | |
| Drug | Cocaine | ICE2 SYNE1 SRC GRIA2 ATP9B CNKSR2 BCL2 EYA1 RYR3 SGK3 CRY2 NEO1 MAPK14 KIDINS220 TXNDC15 NALF1 KCNJ6 ENTPD2 SNX27 BAMBI LRRC7 PLEC IKBKB DNAH8 PRL | 7.82e-05 | 1314 | 187 | 25 | ctd:D003042 |
| Drug | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline | 8.91e-05 | 29 | 187 | 4 | ctd:C568862 | |
| Drug | Dehydroepiandrosterone Sulfate | 8.91e-05 | 29 | 187 | 4 | ctd:D019314 | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 1.89e-05 | 9 | 182 | 3 | DOID:12700 (biomarker_via_orthology) | |
| Disease | Paranoia | 3.67e-05 | 11 | 182 | 3 | C1456784 | |
| Disease | Malignant neoplasm of breast | DSC3 NET1 SYNE1 UBE2C SRC BCORL1 BCL2 NR2F1 DDX3X SGK3 BMP1 MSH6 TXNDC15 TMTC4 FAM83F N4BP2 MACF1 LRRC7 IKBKB | 3.93e-05 | 1074 | 182 | 19 | C0006142 |
| Disease | testosterone measurement | CACNA1D QPCTL ZAN ICE2 BCORL1 TTC27 SLC24A3 BCL2 EYA1 BIRC6 ADCY6 IFNAR2 MSH6 CMIP TXNDC15 NALF1 GTF3C2 ANAPC1 SKAP1 MACF1 WDR72 | 4.27e-05 | 1275 | 182 | 21 | EFO_0004908 |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 4.87e-05 | 12 | 182 | 3 | DOID:0112182 (is_implicated_in) | |
| Disease | Cocaine-Related Disorders | 9.00e-05 | 117 | 182 | 6 | C0236736 | |
| Disease | prostate cancer (is_implicated_in) | 9.00e-05 | 117 | 182 | 6 | DOID:10283 (is_implicated_in) | |
| Disease | red blood cell density measurement | RALGAPA1 ZYG11A EP400 AFF3 NOX3 BCL2 ANKRD55 FOCAD SKAP1 PLCL2 NR5A2 ULK4 AKAP13 PLEC TRIM48 TBX6 | 1.20e-04 | 880 | 182 | 16 | EFO_0007978 |
| Disease | Cocaine Abuse | 1.41e-04 | 127 | 182 | 6 | C0009171 | |
| Disease | migraine disorder, systolic blood pressure | 1.76e-04 | 18 | 182 | 3 | EFO_0006335, MONDO_0005277 | |
| Disease | Bipolar Disorder | CACNA1D WFS1 DISC1 SYNE1 GRIA2 DGKH BCL2 CRY2 SCN2A ULK4 DNAH8 | 1.97e-04 | 477 | 182 | 11 | C0005586 |
| Disease | Physiological Sexual Disorders | 2.25e-04 | 4 | 182 | 2 | C0237873 | |
| Disease | Cocaine Dependence | 2.31e-04 | 139 | 182 | 6 | C0600427 | |
| Disease | Nystagmus | 2.83e-04 | 21 | 182 | 3 | HP_0000639 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 3.26e-04 | 22 | 182 | 3 | EFO_0009312 | |
| Disease | Distal Renal Tubular Acidosis | 3.74e-04 | 5 | 182 | 2 | C1704380 | |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 4.25e-04 | 24 | 182 | 3 | EFO_0006821, EFO_0006826 | |
| Disease | response to carboplatin | 4.58e-04 | 58 | 182 | 4 | GO_0097328 | |
| Disease | Intellectual Disability | RALGAPA1 DISC1 SYNE1 AFF3 GRIA2 DDX3X SCN1A SNX27 MACF1 ELP2 | 4.87e-04 | 447 | 182 | 10 | C3714756 |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 4.96e-04 | 105 | 182 | 5 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | aspartate aminotransferase measurement | CERS2 IQGAP2 MFHAS1 RNF213 HPSE2 C1GALT1 BCL2 EYA1 STK35 BIRC6 USP8 HARS2 ABCB11 AKAP13 GCN1 | 5.14e-04 | 904 | 182 | 15 | EFO_0004736 |
| Disease | fish consumption measurement | 6.67e-04 | 64 | 182 | 4 | EFO_0010139 | |
| Disease | response to radiation, obesity | 7.79e-04 | 7 | 182 | 2 | EFO_0001073, GO_0009314 | |
| Disease | Seizure, Febrile, Simple | 7.79e-04 | 7 | 182 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 7.79e-04 | 7 | 182 | 2 | C0751057 | |
| Disease | colorectal cancer (implicated_via_orthology) | 8.29e-04 | 30 | 182 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | pursuit maintenance gain measurement | 1.01e-03 | 123 | 182 | 5 | EFO_0008433 | |
| Disease | ovarian cancer (implicated_via_orthology) | 1.03e-03 | 8 | 182 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | Febrile Convulsions | 1.32e-03 | 9 | 182 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.32e-03 | 9 | 182 | 2 | C3502809 | |
| Disease | post-traumatic stress disorder (biomarker_via_orthology) | 1.32e-03 | 9 | 182 | 2 | DOID:2055 (biomarker_via_orthology) | |
| Disease | Adenoma, Microcystic | 1.42e-03 | 36 | 182 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 1.42e-03 | 36 | 182 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 1.42e-03 | 36 | 182 | 3 | C0205646 | |
| Disease | Follicular adenoma | 1.42e-03 | 36 | 182 | 3 | C0205647 | |
| Disease | Papillary adenoma | 1.42e-03 | 36 | 182 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 1.42e-03 | 36 | 182 | 3 | C0205651 | |
| Disease | Adenoma | 1.42e-03 | 36 | 182 | 3 | C0001430 | |
| Disease | oppositional defiant disorder measurement | 1.42e-03 | 36 | 182 | 3 | EFO_0007679 | |
| Disease | mean reticulocyte volume | ZYG11A EP400 IQGAP2 AFF3 C15orf39 BCL2 URB2 USP8 PIGC PLCL2 AKAP13 CDH6 TBX6 | 1.44e-03 | 799 | 182 | 13 | EFO_0010701 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.65e-03 | 10 | 182 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.65e-03 | 10 | 182 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Erectile dysfunction | 1.65e-03 | 10 | 182 | 2 | C0242350 | |
| Disease | carbamazepine-induced hyponatremia, response to oxcarbazepine, oxcarbazepine-induced hyponatremia, response to carbamazepine | 1.65e-03 | 10 | 182 | 2 | EFO_0008484, EFO_0009893, EFO_0009894, EFO_0009895 | |
| Disease | snoring measurement | 1.84e-03 | 84 | 182 | 4 | EFO_0008341 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 1.92e-03 | 85 | 182 | 4 | EFO_0000708, EFO_0006953 | |
| Disease | sleep apnea | 1.93e-03 | 40 | 182 | 3 | EFO_0003877 | |
| Disease | left ventricular ejection fraction measurement | 1.93e-03 | 40 | 182 | 3 | EFO_0008373 | |
| Disease | smoking behavior, BMI-adjusted waist-hip ratio | 2.01e-03 | 86 | 182 | 4 | EFO_0004318, EFO_0007788 | |
| Disease | smoking status measurement | CACNA1D AFF3 ADGRB2 SLC24A3 BIRC6 FOCAD ERCC8 TMTC4 KCNJ3 KCNJ6 SCN2A PLCL2 DNAJC1 SETD3 DNAH8 WDR72 | 2.31e-03 | 1160 | 182 | 16 | EFO_0006527 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.40e-03 | 12 | 182 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.58e-03 | 152 | 182 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.82e-03 | 13 | 182 | 2 | C0751122 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 2.82e-03 | 13 | 182 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | Cakut | 2.82e-03 | 13 | 182 | 2 | C1968949 | |
| Disease | diastolic blood pressure, systolic blood pressure | CACNA1D PEX3 GLRA3 SLC24A3 KIAA1671 MSH6 PIEZO2 CMIP PLXNC1 N4BP2 ULK4 | 3.09e-03 | 670 | 182 | 11 | EFO_0006335, EFO_0006336 |
| Disease | Abnormality of refraction | CACNA1D TPRA1 C1GALT1 CNKSR2 STK35 BIRC6 DDX3X BMP7 SCN2A ULK4 AKAP13 | 3.20e-03 | 673 | 182 | 11 | HP_0000539 |
| Disease | hearing impairment | 3.22e-03 | 98 | 182 | 4 | C1384666 | |
| Disease | fertility measurement | 3.28e-03 | 14 | 182 | 2 | EFO_0006923 | |
| Disease | epilepsy (implicated_via_orthology) | 3.48e-03 | 163 | 182 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.66e-03 | 50 | 182 | 3 | EFO_0022247 | |
| Disease | MMR-related febrile seizures | 3.77e-03 | 15 | 182 | 2 | EFO_0006519 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.85e-03 | 103 | 182 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | sodium measurement | 3.85e-03 | 103 | 182 | 4 | EFO_0009282 | |
| Disease | empathy measurement | 4.16e-03 | 170 | 182 | 5 | EFO_0009183 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CACNA1D AFF3 ADGRB2 SLC24A3 BIRC6 MSH6 MAPK14 KCNJ3 KCNJ6 SCN2A PLCL2 DNAJC1 | 4.24e-03 | 801 | 182 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | immature platelet count | 4.27e-03 | 106 | 182 | 4 | EFO_0803544 | |
| Disease | phosphatidylcholine 38:6 measurement | 4.29e-03 | 16 | 182 | 2 | EFO_0010388 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 4.29e-03 | 16 | 182 | 2 | C0393706 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4.31e-03 | 53 | 182 | 3 | C1961099 | |
| Disease | comparative body size at age 10, self-reported | 4.71e-03 | 420 | 182 | 8 | EFO_0009819 | |
| Disease | endometriosis | 4.88e-03 | 252 | 182 | 6 | EFO_0001065 | |
| Disease | antisaccade response measurement | 5.03e-03 | 56 | 182 | 3 | EFO_0006874 | |
| Disease | hemoglobin A1 measurement | 5.17e-03 | 520 | 182 | 9 | EFO_0007629 | |
| Disease | urate measurement, bone density | ATP6V1B1 CRACR2A SYNE1 TAF1B NAALADL2 DNAH14 KIDINS220 GBP4 PLXNC1 DNAH8 | 5.27e-03 | 619 | 182 | 10 | EFO_0003923, EFO_0004531 |
| Disease | taurochenodeoxycholate measurement | 5.42e-03 | 18 | 182 | 2 | EFO_0010537 | |
| Disease | serum IgG measurement | 5.42e-03 | 18 | 182 | 2 | EFO_0004565 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 5.42e-03 | 18 | 182 | 2 | HP_0002373 | |
| Disease | Malignant neoplasm of endometrium | 5.42e-03 | 18 | 182 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 5.42e-03 | 18 | 182 | 2 | C0346191 | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 5.55e-03 | 58 | 182 | 3 | DOID:10652 (biomarker_via_orthology) | |
| Disease | Drug habituation | 5.69e-03 | 115 | 182 | 4 | C0013170 | |
| Disease | Drug abuse | 5.69e-03 | 115 | 182 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.69e-03 | 115 | 182 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 5.69e-03 | 115 | 182 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 5.69e-03 | 115 | 182 | 4 | C0013222 | |
| Disease | Drug Dependence | 5.69e-03 | 115 | 182 | 4 | C1510472 | |
| Disease | Substance Dependence | 5.69e-03 | 115 | 182 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 5.69e-03 | 115 | 182 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.69e-03 | 115 | 182 | 4 | C0029231 | |
| Disease | cholesterol in medium HDL measurement | 5.82e-03 | 59 | 182 | 3 | EFO_0021903 | |
| Disease | insulin resistance | 5.82e-03 | 59 | 182 | 3 | EFO_0002614 | |
| Disease | Substance abuse problem | 5.86e-03 | 116 | 182 | 4 | C0740858 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFWSKLITLIVSIIE | 1046 | Q9UPW8 | |
| LDTWSLVLEKFQSLV | 511 | Q14146 | |
| AFWRFIKSERSIILL | 956 | O60241 | |
| DEIRSLWVKIDLTLL | 761 | P51826 | |
| PSASLILKALERDFW | 1391 | Q96L91 | |
| LSKEFGLRLDSRWSL | 271 | P26439 | |
| IFASDSTRSELRKKW | 331 | Q6DHV7 | |
| EKSKLLSDISARLWF | 41 | Q8WYN0 | |
| LLWFILRVLDTSDAL | 3081 | Q9NR09 | |
| TLSKEFGLRLDSRWS | 271 | P14060 | |
| VESTARLDFLWKLQA | 916 | O43306 | |
| LFRTETQSEKLRWIS | 1481 | Q12774 | |
| WFLFSDVLKRLKLSS | 1696 | Q5H9F3 | |
| LEAESWSRIIDSKFL | 1971 | Q12802 | |
| ISASRWLLKRGELFL | 496 | Q5VV41 | |
| FLSKILTSKFLRRWE | 71 | Q8IY22 | |
| IIAFSFSWKLSLVIL | 891 | O95342 | |
| ALVVWKIFTLSRATA | 451 | Q86Y34 | |
| DLTDKQSFLSVRRWL | 626 | Q9BSW2 | |
| TEIEDDKFLWLSVLR | 881 | Q008S8 | |
| VWTVSSSDKLLDRLL | 506 | Q3KP44 | |
| DDIKSTSSRLWLKFV | 516 | P13497 | |
| SDLFLLDSRTLWASE | 206 | P18075 | |
| WSLLFSIASDVKRKD | 191 | Q96G23 | |
| WSIYLEKQLDELLSR | 171 | Q96KC8 | |
| FWTAKDLTEEIRSLT | 601 | Q9NRI5 | |
| LTKVRDAALWLETLS | 551 | O94823 | |
| DFALKVLNWDSRTLV | 61 | Q13637 | |
| RKFLEATLRSLTAGW | 116 | Q9NXS2 | |
| TDQVSLLRLTWSELF | 246 | P10589 | |
| FWEAALLLSLVATKE | 16 | O75311 | |
| STEVLESFKLARESW | 406 | Q9NVR2 | |
| TDLFTTLVDLQWRLS | 46 | Q92806 | |
| LVVAFSKKWLDLSRS | 96 | Q2M2E3 | |
| SPFSRKLDLWSFLDI | 296 | Q7Z628 | |
| LLTTALVSWLSAKED | 46 | Q7Z5J8 | |
| LWQIKLVLEFFSSRS | 1811 | Q9H1A4 | |
| FLISLGKSWLDSLVL | 656 | Q7RTW8 | |
| WVEESDKRSFLLDLL | 421 | O00571 | |
| EDFSLIESLKFWRTR | 931 | O75140 | |
| RKILFEDFRSWLSDI | 116 | Q8N543 | |
| EDFRSWLSDISKIDL | 121 | Q8N543 | |
| LTKLLVTEDWFSDIS | 921 | Q9ULH0 | |
| SWLSLRLFDEGTISK | 146 | Q8IYB1 | |
| AVTLRSLRSWLSLKD | 756 | Q9BY89 | |
| LAKDAWEISRSSITL | 251 | P09769 | |
| TEFGITSDKLLLAWR | 501 | O14920 | |
| EDISALRALKILWLS | 221 | Q9Y4C4 | |
| SFTKLKELAALWLSD | 386 | Q96NW7 | |
| FTTLVDLKWRFNLLI | 81 | P48051 | |
| SFESRDLLIDEWKSL | 326 | Q16539 | |
| RSLSFKTFLIWVLIS | 1006 | O43861 | |
| ELLSLSREKLWDSEL | 401 | Q76MJ5 | |
| RKGTDFSSWVVLLLL | 456 | Q9Y5L3 | |
| DDSLVSKFIERWSTL | 266 | P42262 | |
| IHSVLEKLFRSIWSL | 1361 | O60486 | |
| FSKRTLSWRLLGEAL | 171 | Q8N119 | |
| SRKEKWDLQALRFLS | 291 | P43116 | |
| LEIWEDLKIISFTRS | 101 | P56589 | |
| WSLGALLELESREKL | 2356 | Q96JB1 | |
| IEALTDSWLTLALKA | 471 | Q99502 | |
| AFWISKDSLADRALL | 386 | Q1KMD3 | |
| FSASERLSLKRELSW | 91 | Q9UBX0 | |
| FIWTVRDFTLELKLD | 191 | Q96PP9 | |
| FIWTVRDFTLELKLD | 176 | Q8N8V2 | |
| SLLAALEEESWRTKA | 1501 | Q92616 | |
| RKWLKSSSLQDFDIR | 1111 | Q07864 | |
| WLFDKTSSEASIRLE | 531 | O94886 | |
| LTRDRAFESTLKSWE | 946 | Q86XP1 | |
| GWLDFLSSKRLVTLA | 91 | Q8WWQ2 | |
| QFWDASKTLRTLLEE | 626 | P52701 | |
| LLVFFRTEAILKASW | 2126 | A2RRP1 | |
| LLWSLSSLREQKELD | 36 | Q9HC58 | |
| ILATASADSRVKLWD | 201 | Q13216 | |
| SLISWNYLRKDLDLV | 956 | Q9UPN3 | |
| QLESLESRWTELLSK | 5426 | Q9UPN3 | |
| SDVWGRKSFLLLTVF | 96 | Q96MC6 | |
| RESWKALERASFSKL | 206 | Q9H8H3 | |
| AIILASWSALAVFVK | 2226 | Q7Z442 | |
| FKISLRNFRSILSWE | 41 | P48551 | |
| TRKSLFKLRSTWDEI | 111 | O94913 | |
| LLFFWLDRSVLAKEL | 21 | P15309 | |
| LLWITALAIKFTLID | 26 | Q8NFZ3 | |
| ALWEAKGLTLLSRLE | 26 | K7EIQ3 | |
| DLILRTSFVDLWLKR | 3966 | Q9C0G6 | |
| LFLWSLRREFTDETK | 101 | Q05DH4 | |
| SLLSDVLKIWVTDTF | 306 | Q8N6C5 | |
| LTESELCRLWTESLL | 786 | Q659A1 | |
| SIILFALQDTKISEW | 76 | Q8TCB0 | |
| LSSKARWLAEELNLF | 536 | Q6ZP82 | |
| ALSDKKRSFTIWLSD | 86 | Q14574 | |
| ELTSSKELWFRAAVI | 141 | Q13145 | |
| WRFLLQSLEDLDTSL | 71 | Q49AN0 | |
| QLLIDSAKDFSKRLW | 1131 | Q9H799 | |
| IDVKLLSAETTLFWN | 746 | Q9UFH2 | |
| LFETDVLSSWRESAK | 896 | Q5T1B0 | |
| ASTWRKKLYLSTEID | 2576 | Q0VDD8 | |
| LLLKRLDLTTSAFHW | 231 | Q17RN3 | |
| DTYVILDNLRWLLSK | 171 | Q9NS00 | |
| FTSKLLDRETLLWHN | 441 | P55285 | |
| LRKDLTTELSWELTI | 686 | Q8N766 | |
| EKFLLAVSRDRTWSL | 626 | Q6IA86 | |
| RKLSDLVWTSDALSD | 126 | Q96LM9 | |
| LLFRSSEILWNLLEK | 256 | A5D8W1 | |
| WLLKAVTFIDLTTLS | 46 | Q9Y315 | |
| SQDIALLKLRDSISW | 126 | E5RG02 | |
| LTAWSILEELLEKDR | 386 | Q96BR1 | |
| LEKEIERLESALSLW | 281 | Q68D86 | |
| LLWLTALAIKFTLID | 26 | Q8N0W4 | |
| IRTLLWTFIKSFQAL | 1336 | Q01668 | |
| LWSLLSEATGKIFDL | 1526 | Q5VW36 | |
| KTLLSYSELWKSSLR | 86 | Q8TBJ5 | |
| LDLLSQRLYWVDSKL | 591 | Q14114 | |
| WLLTDAKRTVLSRAA | 321 | Q8WUT4 | |
| IVEWARSSIFFRELK | 356 | O00482 | |
| KDFLSLIVSILRSWN | 106 | P01236 | |
| LFEASDLSRETSIWK | 336 | Q5T7P8 | |
| SVFESLDLGWKLLRI | 466 | P15313 | |
| LRAHFTIWDKLLERS | 306 | Q9NYK5 | |
| RFTIKSDVWSFGILL | 441 | P12931 | |
| SLARKASLWLFLSSE | 91 | Q8IWZ4 | |
| LARKVSLWLFLSSEE | 76 | P0CI25 | |
| FLQERLKLIAELWDS | 421 | P49590 | |
| IEETLLLEFWTFLSR | 286 | Q4G0N8 | |
| DELLLSFSVWIKLFL | 1771 | Q8NF91 | |
| VWSLLFLRSLDVVAE | 191 | Q9H7F4 | |
| LKLLFLLDDSFEWSL | 366 | Q53T94 | |
| RADLLIWLVTFTATI | 471 | Q9BXS9 | |
| IWSASEELLLRFQAT | 656 | Q13576 | |
| ASLRTLWIKTVDEVF | 906 | Q9UPR0 | |
| ELSFFTRTAWLALTL | 441 | Q9UK23 | |
| VASLVSTRFIKLTWR | 446 | Q92859 | |
| LWTFLEDRASLLLKT | 426 | Q86TU7 | |
| SLWTEELKILRASAE | 416 | Q9NVD3 | |
| WKSELSYELDRLLTE | 151 | Q96M29 | |
| RWADLKSALVFITFT | 116 | Q92535 | |
| WFADLLLSLETRMSE | 451 | Q9HBY0 | |
| ESAWRLESFLKDLVT | 366 | Q8NEG4 | |
| ERETLLLDAWLTTKA | 3111 | Q9NRC6 | |
| DLLDAKYLRTTLQIW | 271 | Q8N434 | |
| WLDFLIVDVSLVSLT | 1286 | P35498 | |
| DFSWLSLKTLLSLAL | 211 | P10415 | |
| LAFWRSKESRSLKES | 146 | Q8IXR9 | |
| LIGAAKSLLAWLDRS | 131 | Q8WXI2 | |
| TLKARFRSLLETAWL | 1001 | Q6ZRI6 | |
| ATWKSLDLIESLLRL | 446 | A5YKK6 | |
| TTQKRRWDFLDILLS | 276 | Q86W10 | |
| IRASLISAVSDKLRW | 226 | Q99816 | |
| VFLSTWNKLRRSLET | 4831 | Q63HN8 | |
| LRKSVETRDWLSTLE | 591 | Q9UID3 | |
| LIKSISDWRVIALAA | 346 | Q5T4D3 | |
| TVADKILWEITRFFL | 111 | Q86W33 | |
| VELALAEFWALTSLK | 241 | Q8TDR2 | |
| SRLVSASDDKTLKLW | 96 | Q86VZ2 | |
| YISRELWDDLLSVLS | 636 | Q6GYQ0 | |
| NLDWLISKLDRLESS | 541 | Q15413 | |
| LLLFSSATDAAIRVW | 166 | Q12788 | |
| SLLVALLEKTTWVDR | 1211 | A6NE52 | |
| LARKVSLWLFLSSEE | 76 | P0CI26 | |
| STLIKSVDWLLVFSL | 316 | Q96J42 | |
| WLDFLIVDVSLVSLT | 1276 | Q99250 | |
| LALELDFWTKNRTVS | 251 | O43280 | |
| GELASKILFTITFWL | 581 | Q9H5I5 | |
| EADLSLLKLISCWRD | 966 | Q3MJ13 | |
| TIRKWLFTTEEEILL | 356 | Q96L92 | |
| VSLSLENRELWKEFS | 91 | O95947 | |
| QLIRSWSLATFRTLK | 1041 | Q15149 | |
| KTISSLFFLLWVLAE | 6 | Q8TE23 | |
| LTRTLLTFFDLAWRL | 46 | Q96HG1 | |
| DSLRTVVIWALSLAL | 296 | Q8N357 | |
| ILRTQDSWRKTFLTE | 166 | Q9NYT6 | |
| SSLLRKLEFWASSVE | 506 | Q49AG3 | |
| WIATIEALLSKSFDA | 2191 | Q9UPU5 | |
| RARKASLWLFLSSEE | 76 | C9J1S8 | |
| NSIKRFLSTELAWLL | 651 | Q8WUA4 | |
| LARKVSLWLFLSSEE | 76 | A6NDI0 | |
| LVSASRDKTLRVWDL | 186 | Q9Y6I7 | |
| LYRALVSTKWLAESI | 6 | Q16762 | |
| WTLFLDYLTSKIKSR | 421 | Q96QU8 | |
| AVLFTEAEWKRLSLE | 41 | Q86UQ0 | |
| FWAIQTSALILRTKL | 381 | Q6P3X3 | |
| VTFLFTLKALWNLTD | 531 | Q6WRX3 | |
| VVLLDWFSSAKDLQI | 256 | P40818 | |
| WVDQISFLLKDLSSL | 201 | Q86WV1 | |
| EWRLFSLRLLSETTS | 946 | Q96C45 | |
| KWSALYDVRTILLSI | 121 | O00762 | |
| ARWFTSLELTKIAVT | 586 | O76024 | |
| WTLLLLVGAALFRKE | 6 | Q9Y493 | |
| RYLSDLFTTLVDLKW | 66 | P48549 | |
| LATLLITIKTWFVRD | 356 | Q86W25 | |
| QKWRLSLASLLFFTV | 36 | B1AL88 | |
| LDEKTSRFSILIEAW | 736 | Q58DX5 | |
| KDIIWATSLLLDSET | 1116 | Q86UW6 |